Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

Table 5

Comparison of the frequency of adverse effects related to medication between the 2 groups.

Adverse effects, (%)	Treatment group		value
	ALC group ()	Placebo group ()
Nausea	7 (20.6%)	3 (8.6%)	0.19
Dyspepsia	5 (14.7%)	2(5.7%)	0.26
Headache	4 (11.8%)	2 (5.7%)	0.43
Diarrhea	2 (5.9%)	0 (0.0%)	0.24

Note: ALC = acetyl-L-carnitine.